U.S. Personal Products Stock News

Vaxcyte (PCVX) has begun dosing participants in its OPUS-3 Phase 3 trial of VAX-31 in previously vaccinated adults, a pipeline milestone aligned with the FDA that is drawing fresh attention to the stock. See our latest analysis for Vaxcyte. The OPUS-3 dosing news comes as Vaxcyte’s share price has shown strong recent momentum, with a 20.6% 30 day share price return and a 20.9% year to date gain, even though the 1 year total shareholder return is a 32.6% decline and the 5 year total...

In recent days, MercadoLibre has accelerated spending on logistics, free shipping, and its Mercado Pago fintech platform across Latin America to strengthen its position against intensifying competition from Sea Limited, JD.com, and others. This push to deepen logistics coverage and financial services reach is reshaping the balance between growth investment and near-term profitability across MercadoLibre’s ecosystem. We’ll now examine how MercadoLibre’s heavier logistics and fintech...

If you are wondering whether Scorpio Tankers is still good value after a strong run, this article is going to focus squarely on what the current share price implies. The stock last closed at US$70.74, with returns of 1.2% over 7 days, 19.7% over 30 days, 42.4% year to date and 71.0% over the past year, which raises fair questions about how much upside or risk is now priced in. These gains sit against a backdrop of sector focused headlines around product tanker demand, vessel supply and...

Heico Corporation recently became the focus of investor attention ahead of its January 2026 quarterly results, as analysts projected higher revenues alongside a year-over-year earnings increase. However, a downward shift in the most recent earnings estimate versus consensus, reflected in an Earnings ESP of 3.07%, highlights growing uncertainty around whether Heico can outperform expectations despite its favorable Zacks Rank of 2. Next, we’ll examine how softer near-term earnings sentiment,...

In February 2026, Intercontinental Exchange, Inc. launched exclusive Polymarket Signals and Sentiment prediction-market data for institutions, rolled out cryptocurrency futures tied to CoinDesk indices, upgraded its MSP mortgage servicing user experience, introduced FTSE South Korea RIC Capped Index Futures, raised its quarterly dividend to US$0.52 per share, and authorized a new US$3.00 billion share repurchase program alongside reporting higher 2025 revenue and net income. Together, these...

Houlihan Lokey (HLI) has drawn fresh attention after recent share price moves, with the stock showing a one-month return of about a 13% decline and a past three-month return of about a 3% decline. See our latest analysis for Houlihan Lokey. The recent 12.54% 30-day share price decline at Houlihan Lokey sits against a softer year-to-date share price return of a 5.81% decline, even as the 5-year total shareholder return of 180.86% points to a much stronger long-term picture. This suggests...

Moody's (MCO) has just posted third quarter FY 2025 revenue of US$2.0b and basic EPS of US$3.61, with trailing twelve month revenue at US$7.5b and EPS at US$12.48 framing the latest print within a larger earnings run rate. The company has seen quarterly revenue move from US$1.82b in Q2 2024 to US$1.90b in Q2 2025 and then US$2.01b in Q3 2025, while basic EPS moved from US$3.03 to US$3.22 and then US$3.61 over the same quarters, giving investors a clear view of how the income statement is...

LiveRamp Holdings (RAMP) drew fresh investor attention after appointing Kristi Argyilan, Global Head of Advertising at Uber, to its Board of Directors, highlighting her long track record in retail media and advertising leadership. See our latest analysis for LiveRamp Holdings. That board appointment comes after a busy few weeks for LiveRamp, with solid third quarter earnings, fresh guidance and ongoing share buybacks drawing attention to a share price that has a 7 day share price return of...

Viking Therapeutics reported a full-year 2025 net loss of US$359.64 million, with basic loss per share widening to US$3.19 from US$1.01 a year earlier, and disclosed that it executed no share repurchases under its previously announced buyback program. At the same time, the company is pushing its obesity pipeline forward, including phase 3 development of injectable VK2735 and planned late-stage trials for its oral counterpart and a dual amylin–calcitonin receptor agonist. We’ll now examine...

Goosehead Insurance (GSHD) closed FY 2025 with fourth quarter revenue of US$105.3 million and basic EPS of US$0.50, alongside trailing twelve month revenue of US$365.3 million and EPS of US$1.11 that frame the latest print in a wider context of reported earnings. Over the past six quarters, revenue has moved from US$77.8 million in Q3 2024 to US$105.3 million in Q4 2025, while quarterly EPS has ranged from US$0.09 in Q1 2025 to US$0.60 in Q4 2024. This gives investors a clearer view of how...

In February 2026, STBL announced a partnership with Hamilton Lane and Securitize to launch a real‑world‑asset‑backed stablecoin on OKX’s X Layer blockchain, using a feeder fund into Hamilton Lane’s Senior Credit Opportunities Fund as part of the collateral structure to support regulated onchain financial products. An important aspect of this initiative is the use of Hamilton Lane’s institutional private credit exposure within a tokenized framework, positioning the firm at the intersection of...

In February 2026, Diebold Nixdorf reported that it had completed two share repurchase programs totaling 2,307,275 shares for US$150.57 million and announced fourth-quarter 2025 net income of US$49.6 million, with full-year 2025 net income of US$94.6 million following a loss a year earlier. At the same time, Arena Capital Advisors fully exited its roughly US$35 million position, meaning improved profitability and capital returns are unfolding alongside a complete withdrawal by one of the...

Fiverr International (FVRR) just posted its FY 2025 numbers with Q3 revenue of US$107.9 million and basic EPS of US$0.15, set against trailing twelve month revenue of US$427.4 million and EPS of US$0.62 that reflect earnings growth of 121.2% over the past year. The company has seen quarterly revenue move from US$94.7 million in Q2 2024 to a range of roughly US$107 million to US$108.6 million across the first three quarters of 2025. Over the same 2025 periods, basic EPS shifted from US$0.09 in...

If you are wondering whether Oddity Tech's share price reflects its true potential, this article walks through how the current market price lines up with several valuation checks. The stock last closed at US$29.98, with a 2.8% return over the past 7 days, a 15.3% decline over 30 days, and a 24.0% decline year to date, while the 1 year return sits at a 32.6% decline. Recent coverage of Oddity Tech has focused on its position within the household and beauty space, including how its digital...

If you are wondering whether PG&E's current share price reflects its true value, you are not alone. Many investors are asking the same question as the stock trades around US$17.88. Over the short to medium term, PG&E has recorded returns of 4.6% over 7 days, 14.5% over 30 days, 9.9% year to date, 15.1% over 1 year and 16.5% over 3 years, while the 5 year figure stands at 58.5%. Recent headlines around PG&E have continued to focus on the company and its role in the California utilities...

Regulatory milestone puts TMC the metals (NasdaqGS:TMC) in focus TMC the metals (NasdaqGS:TMC) has moved into the spotlight after securing a key permitting milestone for its deep sea mining projects, a development tied directly to progressing its polymetallic nodule assets toward commercialization. See our latest analysis for TMC the metals. The permitting milestone comes after a mixed stretch for the stock, with a 1 day share price return of 1.20% to US$5.90, a 30 day share price return...

Hinge Health (NYSE:HNGE) has completed a share buyback, repurchasing over 10% of its shares. The buyback signals management's confidence in the company and its current valuation. For investors, the key point is that Hinge Health has taken more than 10% of its own stock off the market. With shares at $40.56 and a value score of 4, the company is pairing an active capital decision with a relatively low internal value rating. This combination can draw attention from investors who focus on...

In February 2026, Teradata reported its fourth-quarter and full-year 2025 results, showing modest year-over-year revenue growth in Q4 to US$421 million, higher quarterly and annual net income, and improved diluted EPS alongside updated 2026 guidance calling for broadly flat revenue and earnings in the range of US$0.36–US$0.40 for Q1 and US$1.26–US$1.36 for the full year. Management also highlighted stronger customer uptake of Teradata’s AI-focused and hybrid cloud offerings, while the...

Starboard Value has launched an activist campaign targeting Tripadvisor's board, seeking to replace a majority of directors. The investor is urging Tripadvisor to consider options to maximize shareholder value, including a possible sale of the company. Starboard has criticized Tripadvisor's strategic direction, use of Generative AI, and past decisions it views as unfavorable to shareholders. For anyone tracking NasdaqGS:TRIP, this campaign comes after a challenging stretch for the stock...

Bausch Health Companies (NYSE:BHC) is back in focus after reporting its eleventh consecutive quarter of revenue and adjusted EBITDA growth, while posting a quarterly net loss and missing earnings expectations. See our latest analysis for Bausch Health Companies. Despite the recent earnings miss and quarterly net loss, investors have reacted with a 1-day share price return of 3.34% to US$6.19. However, the 30-day share price return of 11.32% and year-to-date share price return of 14.15%...

Consolidated Edison recently declared a higher quarterly dividend, extending its streak of annual increases to 52 years and reaffirming its status as a Dividend King, alongside preparing to report fourth-quarter and full-year results. This combination of a long-running commitment to growing shareholder payouts and upcoming earnings has sharpened attention on how the utility balances income stability with future investment needs. Next, we will explore how Consolidated Edison’s 52-year...

IDEAYA Biosciences (IDYA) has wrapped up FY 2025 with Q4 revenue of US$10.9 million, a basic EPS loss of US$0.94, and net income excluding extra items at a loss of US$83.3 million. Trailing twelve month figures show revenue of US$218.7 million and a basic EPS loss of US$1.28. Over recent quarters, the company’s revenue moved from US$7.0 million in Q4 2024 to US$207.8 million in Q3 2025 before landing at US$10.9 million in Q4 2025. Basic EPS ranged from a loss of US$1.49 in Q4 2024 to a profit...

Royal Caribbean Cruises Ltd. (NYSE:RCL) has appointed Christopher J. Wiernicki to its Board of Directors. Wiernicki brings extensive experience in marine engineering, digitalization, and safety to the company. The appointment is positioned to support Royal Caribbean's ongoing work on operational discipline and clean energy transition. Royal Caribbean, one of the major players in global cruising, sits at the intersection of travel, marine engineering, and large scale hospitality. As the...

Morgan Stanley’s recent upgrade of Allegro MicroSystems (ALGM), paired with earnings that topped expectations, has focused attention on how the new ACS37017 current sensor and leadership changes could shape the stock’s risk reward profile. See our latest analysis for Allegro MicroSystems. The recent 1 day share price decline of 7.44% and 7 day share price return of negative 9.86% sit against a stronger backdrop, with a 90 day share price return of 69.25% and 1 year total shareholder return of...